Liraglutide protects against lethal renal ischemia-reperfusion injury by inhibiting high-mobility group box 1 nuclear-cytoplasmic translocation and release
Yakun Li, Bingyang Xu, Jun Yang, Lu Wang, Xiaosheng Tan, Xiaofan Hu, Lingjuan Sun, Song Chen, Lan Zhu, Xiaoping Chen, Gang Chen
Topics & Concepts
LiraglutideHMGB1MedicinePharmacologyRenal ischemiaKidneyDownregulation and upregulationEndocrinologyInternal medicineReperfusion injuryIschemiaChemistryReceptorDiabetes mellitusBiochemistryType 2 diabetesGeneAdvanced Glycation End Products researchDiabetes Treatment and ManagementHyperglycemia and glycemic control in critically ill and hospitalized patients